<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:biib="http://www.biogenidec.com/20211118" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2021-11-18_to_2021-11-18">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2021-11-18_to_2021-11-18">0000875045</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="biib-20211118.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2021-11-18_to_2021-11-18"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000875045</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-11-18</xbrli:startDate> <xbrli:endDate>2021-11-18</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2021-11-18_to_2021-11-18">8-K</ix:nonNumeric></p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2021-11-18_to_2021-11-18" format="ixt:datemonthdayyearen">November 18, 2021</ix:nonNumeric></p> <p style="font-size:14pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:1pt; margin-bottom:0pt; font-size:24pt; font-family:ARIAL;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2021-11-18_to_2021-11-18">Biogen Inc.</ix:nonNumeric> </p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:ARIAL; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:45%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:22%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:31%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2021-11-18_to_2021-11-18" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2021-11-18_to_2021-11-18">0-19311</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2021-11-18_to_2021-11-18">33-0112644</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top">(State or other jurisdiction of incorporation)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top">(Commission File Number)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top">(IRS Employer Identification No.)</td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:ARIAL; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:100%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2021-11-18_to_2021-11-18">225 Binney Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2021-11-18_to_2021-11-18">Cambridge</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2021-11-18_to_2021-11-18" format="ixt-sec:stateprovnameen">Massachusetts</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2021-11-18_to_2021-11-18">02142</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top">(Address of principal executive offices; Zip Code)</td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL;text-align:center">Registrant&#8217;s telephone number, including area code: <span style="font-weight:bold"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2021-11-18_to_2021-11-18">(617)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2021-11-18_to_2021-11-18">679-2000</ix:nonNumeric></span></span></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><span style="font-family:Times New Roman"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2021-11-18_to_2021-11-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p> <p style="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><span style="font-family:Times New Roman"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2021-11-18_to_2021-11-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p> <p style="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><span style="font-family:Times New Roman"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2021-11-18_to_2021-11-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p> <p style="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><span style="font-family:Times New Roman"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2021-11-18_to_2021-11-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:ARIAL; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:32%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:20%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<td style="BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom"> <p style="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL;text-align:center">Title of each class</p> <p style="font-size:2pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"> <p style="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL;text-align:center">Trading&#160;Symbol(s)</p> <p style="font-size:2pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"> <p style="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL;text-align:center">Name of each exchange on which registered</p> <p style="font-size:2pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<td style="BORDER:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-11-18_to_2021-11-18">Common Stock, $0.0005 par value</ix:nonNumeric></p> <p style="font-size:1pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-11-18_to_2021-11-18">BIIB</ix:nonNumeric></p> <p style="font-size:1pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-11-18_to_2021-11-18" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric></p> <p style="font-size:1pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr></table> <p style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><span style="font-family:Times New Roman"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2021-11-18_to_2021-11-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span> &#160;Emerging growth company</p> <p style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;<span style="font-family:Times New Roman">&#9744;</span></p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:14%;vertical-align:top" align="left"><span style="color:#0075c9"><span style="font-weight:bold">Item&#160;8.01</span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:ARIAL;text-align:left"><span style="color:#0075c9"><span style="font-weight:bold">Other Events. </span></span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><span style="text-decoration:underline">Tecfidera CHMP Update </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">On November&#160;18, 2021, Biogen received an Opinion adopted by The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) at its November meeting on the ad hoc assessment relating to the therapeutic effect of monoethyl fumarate salts (MEF) within Fumaderm for the purpose of implementation of the May&#160;5, 2021 Judgment of the General Court <span style="white-space:nowrap">(Case&#160;T-611/18)</span> annulling the EMA&#8217;s <span style="white-space:nowrap">non-validation</span> decision for a generic application of Tecfidera and in connection with a number of pending applications before the CHMP which concern dimethyl fumarate. The Company, the EMA, and the European Commission have each appealed the General Court&#8217;s decision as wrongly decided. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The CHMP Opinion states: </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:ARIAL">The CHMP, having considered the matter as set out in the appended <span style="font-style:italic">ad hoc</span> assessment report, is of the opinion that taking into account the described results, including the severe methodological limitations of the clinical studies, it cannot be concluded based on these data that a clinically relevant therapeutic effect of MEF in Fumaderm has been demonstrated. </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:ARIAL">Therefore, the CHMP concludes that the totality of the available data cannot establish that MEF exerts a clinically relevant therapeutic contribution within Fumaderm. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:12pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:14%;vertical-align:top" align="left"><span style="color:#0075c9"><span style="font-weight:bold">Item&#160;9.01</span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:ARIAL;text-align:left"><span style="color:#0075c9"><span style="font-weight:bold">Financial Statements and Exhibits. </span></span></p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%;vertical-align:top" align="left"><span style="font-weight:bold">(d)</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:ARIAL;font-weight:bold;text-align:left">Exhibits </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The exhibits listed below are furnished as part of this Current Report on <span style="white-space:nowrap">Form&#160;8-K</span> </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:13%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:6%"></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:78%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:10pt; font-family:ARIAL">Exhibit&#160;Number</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">Description</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">104</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL;text-align:center"><span style="color:#0075c9"><span style="font-weight:bold">Signatures </span></span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:ARIAL;text-align:justify">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:39%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:2%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:49%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:7%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="5"><span style="font-weight:bold">Biogen Inc.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:24pt"></td>
<td style="height:24pt" colspan="2"></td>
<td style="height:24pt" colspan="2"></td>
<td style="height:24pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:ARIAL">&#160;&#160;/s/ Wendell Taylor</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;&#160;Wendell Taylor</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;&#160;Chief Corporation Counsel and Assistant Secretary</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
</table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Date: November&#160;19, 2021 </p>
</div></div>

</body></html>
